Semi-Annual Statement Of Cash Flows

KAKEN PHARMACEUTIAL CO., LTD. - Filing #7247222

Concept As at
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2023-03-31
Semi-annual statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
30,039,000,000 JPY
5,903,000,000 JPY
Interest and dividends received
606,000,000 JPY
479,000,000 JPY
Interest paid
-28,000,000 JPY
-17,000,000 JPY
Net cash provided by (used in) operating activities
29,780,000,000 JPY
2,577,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-4,138,000,000 JPY
-1,861,000,000 JPY
Purchase of investment securities
-400,000,000 JPY
JPY
Proceeds from sale of investment securities
520,000,000 JPY
516,000,000 JPY
Other, net
269,000,000 JPY
-21,000,000 JPY
Net cash provided by (used in) investing activities
-19,650,000,000 JPY
-5,854,000,000 JPY
Cash flows from financing activities
Purchase of treasury shares
-5,935,000,000 JPY
-2,000,000 JPY
Dividends paid
-7,198,000,000 JPY
-5,657,000,000 JPY
Net cash provided by (used in) financing activities
-5,369,000,000 JPY
-5,658,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
JPY
JPY
Net increase (decrease) in cash and cash equivalents
4,760,000,000 JPY
-8,935,000,000 JPY
Cash and cash equivalents
70,085,000,000 JPY
65,325,000,000 JPY
74,260,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.